279|47|Public
5|$|Several {{bioactive}} secondary metabolites {{have been}} isolated and identified from Volvariella bombycina fruit bodies, mycelium, or pure culture. The compounds ergosta-4,6,8(14),22-tetraene-3-one, ergosterol peroxide, indole-3-carboxaldehyde, and <b>indazole</b> {{were found in}} liquid culture. In 2009, the novel compound isodeoxyhelicobasidin was identified from culture broth; this compound inhibits the enzyme human elastase. The fungus also produces compounds that have antioxidative activity.|$|E
25|$|Another compound, the <b>indazole</b> {{derivative}} O-1248, can {{be regarded}} as an analog of rimonabant wherein its 5-aryl group is fused to the pyrazole moiety. However, this structural modification resulted in a 67-fold decrease in CB1 receptor affinity.|$|E
5000|$|Any {{substance}} {{that has a}} 3-carboxamideindazole structure with substitution at the nitrogen atom of the <b>indazole</b> ring, whether or not further substituted on the <b>indazole</b> ring to any extent {{and whether or not}} substituted at the carboxamide group to any extent, including ...|$|E
40|$|Reaction of <b>indazoles</b> with {{aldehydes}} in {{the presence}} of p-toluenesulfinic acid affords the corresponding sulfonyl <b>indazoles</b> in satisfactory yields. The reported Friedel-Crafts process is rather unusual on <b>indazoles</b> because of the reduced electronic density of the heterocycle. The obtained sulfonyl <b>indazoles</b> can be desulfonylated under reductive conditions, finally leading to 3 -alkylated <b>indazoles...</b>|$|R
5000|$|<b>Indazoles</b> {{are rare}} in nature. The {{alkaloids}} nigellicine, nigeglanine, and nigellidine are <b>indazoles.</b> Nigellicine was {{isolated from the}} widely distributed plant Nigella sativa L. (black cumin). Nigeglanine was isolated from extracts of Nigella glandulifera.|$|R
40|$|The {{alkylation}} of 5 -cyano <b>indazoles</b> 2 in {{the presence}} of readily available imidizolium salts (ionic liquids) (Bmim) BF 4 as phase transfer catalyst were performed to afford the regio isomers N 1 -and N 2 -(substituted alkyl) - 5 -cyano <b>indazoles.</b> The N 1 -alkylated cyano <b>indazoles</b> were converted to the corresponding N 1 -(substituted alkyl) - 5 -aminomethyl and 5 -carbaldehydes 5 (a-f) and 6 (a-f) ...|$|R
50|$|<b>Indazole</b> {{derivatives}} {{display a}} broad variety of biological activities.|$|E
5000|$|... (i)replacement of the indole {{ring with}} indane, indene, <b>indazole,</b> pyrrole, pyrazole, imidazole, benzimidazole, pyrrolo2,3-bpyridine, pyrrolo3,2-cpyridine or pyrazolo3,4‑bpyridine; ...|$|E
50|$|It is a {{structural}} analog of AM-2201 {{in which the}} central indole ring {{has been replaced by}} <b>indazole.</b>|$|E
5000|$|... #Subtitle level 2: Synthesis of 3-Substituted <b>Indazoles</b> from Arynes and N-tosylhydrazones ...|$|R
40|$|In {{the absence}} of a steric {{directing}} group, iridium-catalyzed C–H borylation of N-protected <b>indazoles</b> occurs rapidly and selectively at C- 3 and the resulting boronate esters can be utilized in a range of downstream conversions. The functional group tolerance of the iridium-catalyzed C–H borylation reaction enables simple and efficient multidirectional syntheses of substituted <b>indazoles</b> to be realized...|$|R
40|$|Environment-friendly three-component Ugi-type {{strategy}} (U- 3 CR) for {{the synthesis}} {{of a wide variety}} of α-amino amidines has been developed by using silica gel as promoter, and a novel access to amidino substituted <b>indazoles</b> in a regioselective manner is presented via iron(iii) catalyzed post Ugi cyclization strategy. This method allows an easy construction of amidino substituted <b>indazoles</b> in good yields with broad substrate scope starting from readily available starting materials...|$|R
5000|$|... (i) {{replacement}} of the indole ring with indane, indene, <b>indazole,</b> pyrrole, pyrazole, imidazole, benzimidazole, pyrrolo2,3-bpyridine, pyrrolo3,2-cpyridine or pyrazolo3,4-bpyridine; ...|$|E
5000|$|Gamendazole {{is a novel}} drug {{candidate}} for male contraception. It is an <b>indazole</b> carboxylic acid derived from lonidamine (LND).|$|E
50|$|<b>Indazole,</b> {{also called}} isoindazole, is a heterocyclic {{aromatic}} organic compound. This bicyclic compound {{consists of the}} fusion of benzene and pyrazole.|$|E
40|$|The {{inhibition}} of neuronal and inducible nitric oxide synthases (nNOS and iNOS) {{by a series}} of 36 <b>indazoles</b> has been evaluated, showing that most of the assayed derivatives are better iNOS than nNOS inhibitors. A parabolic model relating the iNOS inhibition percentage with the difference, Erel, between stacking and apical interaction energies of <b>indazoles</b> with the active site of the NOS enzyme has been established. © 2011 Elsevier Masson SAS. All rights reserved. Peer Reviewe...|$|R
50|$|Niobium {{chloride}} {{has been}} used in the syntheses of <b>indazoles</b> which can be used as LXR or Liver X receptor inhibitors.|$|R
40|$|This study {{deals with}} a new and {{efficient}} metal-free regioselective synthesis of pyrimido-fused <b>indazoles</b> with nitrogen ring junction motifs. We have developed a metal-free domino type reaction between 3 -aminoindazole, aryl aldehydes and aceotophenones {{in the presence of}} KOH/DMF that leads to pyrimido[1, 2 -b]indazole analogues. Response Surface Methodology (RSM) coupled with a Box-Behnken design (BBD) were utilized for exploring the effect of base used (A), temperature of reaction (B) and (C), reaction time. This approach can allow access to a variety of pyrimidoindazole fluorophores and related compounds. The compound N,N-dimethyl- 4 -(2 -phenylpyrimido[1, 2 -b]indazol- 4 -yl) aniline (4 e) displays the maximum fluorescence intensity at 518 nm and shows a fluorescence quantum yield of 0. 068. The synthesized pyramido-fused <b>indazoles</b> have been evaluated for their free radical scavenging activity and compound 4 f showed good antioxidant activity...|$|R
50|$|THJ-018 is a {{synthetic}} cannabinoid {{that is the}} <b>indazole</b> analogue of JWH-018 and has been sold online as a designer drug.|$|E
5000|$|... (1) “Core component” {{is one of}} the following:  azaindole, benzimidazole, benzothiazole, carbazole, imidazole, indane, <b>indazole,</b> indene, indole, pyrazole, pyrazolopyridine, pyridine, or pyrrole.|$|E
50|$|MDMB-FUBICA's <b>indazole</b> {{analogue}} MDMB-FUBINACA {{has been}} linked to at least 1000 hospitalisations and 40 deaths as a consequence of intoxication as of March 2015.|$|E
40|$|A copper(I) -mediated one-pot {{synthesis}} of 2, 3 -dihydro- 1 H-indazole heterocycles has been developed. This synthetic route provides the desired <b>indazoles</b> in moderate to good yields (55 %– 72 %) which are substantially {{better than those}} achievable with an alternative two-step reaction sequence. The reaction is tolerant of functionality on the aromatic ring...|$|R
40|$|<b>Indazoles</b> and pyrazoles {{are known}} to be pharmaceutically {{relevant}} molecules. In particular their application as both analgesic and antitumoral drugs has been reported. In order to investigate the properties of compounds belonging to these families, we have synthesised new cycloalkylpyrazoles bearing an arylidene group on the cycloalkyl ring, with the aim of modifying the biological profile of these molecules...|$|R
40|$|We have {{successfully}} shown that readily available vinyl dibromides {{in combination with}} copper catalysis are especially effi cient and useful reagents for the alkynylation of benzimidazoles and <b>indazoles.</b> This process allows the direct and straightforward synthesis {{of a variety of}} heterocyclic ynamines, which are otherwise difficult to access and which may provide interesting platforms in drug discovery and material science as well. info:eu-repo/semantics/publishe...|$|R
50|$|Structurally {{it closely}} resembles {{cannabinoid}} compounds from patent WO 2003/035005 {{but with an}} indole core instead of <b>indazole,</b> and a simple pentyl chain on the indole 1-position.|$|E
5000|$|Mohammed [...]A. Al-Haiza, S.A. El-Assiery, G.H. Sayed and A.Fouda, Synthesis of Some New Quinoline, <b>Indazole,</b> Benzisoxazole, Quinazoline and Chromene Derivatives. Al-Azhar Bull. Sci. Vol. 13, No. 1 (June):pp. 75-85, 2002.|$|E
50|$|FAB-144 is an indazole-based {{synthetic}} cannabinoid that {{is presumed}} to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It is the <b>indazole</b> analogue of XLR-11.|$|E
40|$|The {{synthesis}} and {{reactivity of}} &# 945;-oxoketenes dithioacetals (S,S-acetals), general structure [(R¹C=OC(R²) =C(SR³) (SR 4) ], are reported. We also showed {{the application of}} S,S acetals as synthons for efficient synthesis of isoxazoles, pyrazoles, <b>indazoles,</b> thiophenes, dithiol thiones, pyridines, pyrimidines and other heterocycles. This work aims to review the importance of &# 945;-oxoketenes dithioacetals in organic chemistry {{during the past few}} years...|$|R
40|$|The {{reaction}} of 5 -polyfluoroaryl- 1, 2, 4 -oxadiazoles with methylhydrazine {{has been studied}} and the synthesis of fluorinated N-methylindazoles has been realized. Rearrangement reactions showed predominantly formation of N(1) -methylindazole regioisomers. Starting compounds were preliminarily functionalized at the polyfluoroaryl moiety through fluorine displacement with nucleophiles (methanol, methylamine, dimethylamine), allowing the obtainment of target <b>indazoles</b> substituted at the C(6) position...|$|R
40|$|We {{report a}} {{theoretical}} approach, at the M 05 - 2 x/ 6 - 311 +G(d) level, {{to explain the}} affinity of <b>indazoles</b> for nitric oxide synthases using a simplified model of porphyrin. The theoretical Erel = Ei stacking-Ei apical values correlate with the experimental inhibition percents allowing to predict that 3, 7 -dinitro- 1 H-indazole should be a good NOS inhibitor. © 2009 Elsevier Ltd. All rights reserved. Peer Reviewe...|$|R
50|$|Another compound, the <b>indazole</b> {{derivative}} O-1248, can {{be regarded}} as an analog of rimonabant wherein its 5-aryl group is fused to the pyrazole moiety. However, this structural modification resulted in a 67-fold decrease in CB1 receptor affinity.|$|E
5000|$|It {{had never}} {{previously}} {{been reported in}} the scientific or patent literature, and was first identified by laboratories in Japan in March 2012 as an ingredient in synthetic cannabis smoking blends, along with its <b>indazole</b> derivative APINACA (sold as [...] "AKB48").|$|E
50|$|KP1019 is {{synthesized}} by refluxing RuCl3-3H2O with HCl and ethanol. The ethanol {{is removed}} and <b>indazole</b> {{is allowed to}} react with the solution at 70 °C. The resulting solid is collected by filtration and its purity is evaluate by UV-visible spectroscopy, elemental analysis, and determination of reduction potential.|$|E
40|$|International audienceA copper-catalyzed {{oxidative}} C(sp(3)) -H/N-H coupling of NH-heterocycles with affordable (cyclo) alkanes {{has been}} developed. This procedure involves C(sp(3)) -N bond formation through a radical pathway generated by homolytic cleavage of di-tert-butyl peroxide and trapping of the radical(s) by copper catalysts. The reaction tolerates {{a series of}} functional groups, such as bromo, fluoro, ester, ketone, nitrile, methyl, and methoxy. free-NH-containing indoles, pyrroles, pyrazoles, <b>indazoles,</b> and benzotriazoles are successfully N-alkylated...|$|R
40|$|A {{procedure}} {{has been}} developed for synthesis of 2 -alkenyl- 2 H-indazoles starting from 2 -(2 -carbonylmethyl) - 2 H-indazoles, which are prepared by gallium/aluminium- and aluminium-mediated, direct, regioselective alkylation of <b>indazoles</b> with α-bromocarbonyl compounds. The structure of 3 -(2 H-indazol- 2 -yl) - 2 H-chromen- 2 -one was proven by X-ray crystallography. The styrene- and coumarin- 2 H-indazoles produced by using the new method {{were found to have}} interesting fluorescence properties...|$|R
40|$|By {{use of a}} structure-based {{computational}} method for identification of structurally novel Janus kinase (JAK) inhibitors predicted to bind beyond the ATP binding site, a potent series of <b>indazoles</b> was identified as selective pan-JAK inhibitors with a type 1. 5 binding mode. Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in potent pan-JAK inhibitor 2 (PF- 06263276), which was advanced into clinical studie...|$|R
